WeFund Ventures

WeFund Ventures is an early-stage venture capital firm focused on promising projects across biotech and internet sectors. The firm also operates an acceleration fund that provides financing on very early stages. It has an efficient syndicate funding structure that allows to mobilize substantial funds thus keeping great flexibility and speed. Founded in 2017, WeFund Ventures is headquartered in Tallinn, Estonia.

Alex Glotov

Partner

Dmytro Ruzhytskyi

Partner

Alex Skubenko

CEO

2 past transactions

Payris

Seed Round in 2019
Payris is an ecosystem where customers publish their wishes and businesses complete them. Using Payris, consumer can publish a wish, get connected to a supplier who can complete the wish, and get rewarded for making their wishes come true through the app. Vendors may use Payris to buy hot leads and data for research. The platform tackles and solves the problem of social networks collecting and exploiting user data for free – Payris rewards users for sharing their wishes and completing surveys.

A.D.A.M.

Seed Round in 2018
A.D.A.M. is a 3D bioprinting startup focused on developing a Point-of-Care Medical Device Production System specifically for bone implants. The company aims to create personalized, bio-resorbable implants that can be printed and sterilized in-house, allowing medical professionals to improve operational efficiency and reduce costs. A.D.A.M. has established partnerships with reputable institutions such as Mount Sinai, Yale School of Medicine, and the Ministry of Health in Ukraine to support its market entry. The company’s innovative service model involves installing and maintaining its turnkey system at hospitals for a monthly subscription fee, differentiating it from traditional methods that require costly and time-consuming setups. Currently, A.D.A.M. is addressing the lack of end-to-end solutions for 3D printing in medical facilities, aiming to cut costs by over 50% and enhance revenue opportunities for hospitals. The company's long-term vision includes expanding its product offerings to encompass a broader range of bioprinted tissues and organs, ultimately facilitating more accessible medical treatments worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.